Pancreatic Cancer Research

ResearcherPeking UniversityNo recent work listed

Xinglong Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4373-2511; OpenAlex author ID A5081994056. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41421-021-00366-y↗
  2. MicroRNA-634 functions as a tumor suppressor in pancreatic cancer via directly targeting heat shock-related 70-kDa protein 2. First author DOI 10.3892/etm.2019.7433↗
  3. HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ol.2018.9090↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianwen Zhao · 2 shared papers, 2018–2019 · strength 0.27
  2. Danqi Fu · 1 shared paper, 2022 · strength 0.15
  3. Yang Liu · 1 shared paper, 2022 · strength 0.15
  4. Xiaoying Fan · 1 shared paper, 2022 · strength 0.15
  5. Ping Lü · 1 shared paper, 2022 · strength 0.15
  6. Fuchou Tang · 1 shared paper, 2022 · strength 0.15
  7. Jihui Hao · 1 shared paper, 2022 · strength 0.15
  8. Duanrui Chen · 1 shared paper, 2019 · strength 0.14
  9. Xiangwen Zhao · 1 shared paper, 2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.